To support those living in Quebec, the Canadian Cancer Society (CCS) recently launched a new bilingual website. Visit cancertrialscanada.ca to quickly search for and enroll in clinical trials anywhere in Canada with adult cancer patients. As the vehicle for this regional collaboration, this initiative was awarded $440,000 in funding from the Canadian Partnership Against Cancer (CPAC) to help develop it. The site gives patients the tools to independently search for clinical trials that best fit their individual cancer type and needs. This reduces the barriers for them to access potentially life-saving experimental treatments.
To run the new website, CCS has collaborated with Q-CROC, a trial recruitment platform that mainly functions in Quebec. The collaboration aims to enhance the existing trial recruitment services provided by Q-CROC and expand them to a national audience. This change follows CPAC’s controversial decision to close its former home in 2023. Now, CCS is proud to assume this mantle for trial information.
Sandra Krueckl, the executive vice-president of CCS, stresses that this website launch is just the beginning. We can’t overstate how much this benefits Canadian cancer patients.
“We certainly feel that what we need is a made-in-Canada solution,” – Dr. Krueckl
The new, comprehensive, and easy-to-navigate site is focused on delivering clear and truthful information. It’s meant to be a resource for informing you about clinical trials happening here in Canada. Approximately 80 percent of the information available on cancertrialscanada.ca is drawn from clinicaltrials.gov. This trustworthy starting point provides patients a powerful tool to easily search for and access important information.
An Angus Reid survey commissioned by CCS underscored the urgency for such resources. The survey collected responses from over 2,000 Canadians. It showed that more than 50% of respondents, who had no direct experience with cancer themselves, didn’t even know that clinical trials might be an option for treatment. This key gap in awareness speaks to the urgent need for the new https://foodwastefriend.ly/ website. It will help patients and their families understand the clinical trial opportunities that exist for them.
Lucie D’Amours, executive director of Q-CROC, expressed her hope that the website will help cancer patients avoid unreliable online searches.
“It’s easier for me now, but back then, it was really hard,” – Laura Crane
D’Amours stressed the importance of providing patients with a trusted source. In this manner, patients will have the opportunity to consider their alternatives without going to “Dr. Google.”
Under CCS, Q-CROC is collaborating with multiple industry and academic partners to develop fruitful relationships that can advance research into practice. Tobi’s hope is to continue to ensure the content on the site is up-to-date and applicable to today’s Canadian population.
“One where we are building the relationships with industry and academic partners and ensuring that we’ve got that information that is accurate and up to date for the Canadian population,” – Dr. Krueckl
Delivering on CCS’s commitment to developing a “made-in-Canada solution,” this new initiative will help connect cancer patients to available clinical trials. The website serves as a comprehensive and accessible hub. This helps to make sure patients can confidently consider the broadest range of available treatment options.
